Economy/Home · Economy

HLB Chairman Jin Yang-kon Expands Stakes in HLB, HLB Global, and HLB Life Science... HLB Stake Exceeds 10%

HLB Chairman Jin Yang-kon has expanded his holdings across three affiliates by additionally acquiring shares and convertible bonds in HLB, HLB Global, and HLB Life Science (HLB PEP). According to a regulatory filing on the 20th, the shares and other equity securities held by Chairman Jin and 12 rel

Oseong Kwon
Staff Reporter
5 min read
HLB Chairman Jin Yang-kon Expands Stakes in HLB, HLB Global, and HLB Life Science... HLB Stake Exceeds 10%
CBC News

HLB Chairman Jin Yang-kon has expanded his holdings across three affiliates by additionally acquiring shares and convertible bonds in HLB, HLB Global, and HLB Life Science (HLB PEP).

According to a regulatory filing on the 20th, the shares and other equity securities held by Chairman Jin and 12 related parties in HLB increased by 96,369 shares, from 13,332,011 shares at the time of the previous report to 13,428,380 shares, while their ownership ratio rose 0.06 percentage points from 9.95% to 10.01%. The report was triggered by the subscription to convertible bonds and the signing of a call option contract, among other reasons.

Among the equity securities, common share holdings remained unchanged at 12,510,425 shares, with the common share ownership ratio also unchanged at 9.40%. Equity securities subject to major contracts increased from 2,694,153 shares to 3,095,560 shares, with the ratio rising from 2.01% to 2.31%. The filing listed the method and reason for the change as 'subscription to convertible bonds, etc.,' and the reason for the amendment as 'signing of a call option contract, etc.'

Chairman Jin's holdings in HLB Global also increased following an additional acquisition of convertible bonds. The shares and other equity securities held by Chairman Jin and three related parties rose by 2,108,510 shares, from 4,902,221 shares to 7,017,031 shares, with the ownership ratio up 3.54 percentage points from 9.27% to 12.81%. On the 19th, Chairman Jin additionally subscribed to HLB Global convertible bonds. The number of shares to be converted, based on the convertible bonds, increased by 2,093,510 shares, from 1,318,681 shares to 3,412,191 shares. The filing showed the acquisition price at 1,433 won per bond, with 3 billion won required for the acquisition, and the source and purpose of funds listed as 'other bonds.' A related party, Kim Kwang-jae, also purchased a total of 15,000 shares on the market in June, increasing his holdings to 22,000 shares.

In HLB Life Science, Chairman Jin purchased a total of 22,000 common shares on the market from the 14th to the 20th. As a result, his holdings rose from 37,700 shares to 59,700 shares, with his ownership ratio up 0.30 percentage points from 0.32% to 0.62%. The purchase prices ranged from 4,630 won to 4,750 won per share. Meanwhile, the HLB Life Science filing lists Chairman Jin as an inside director.

Oseong Kwon
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.